비오피오이드 진통 패치 시장

Global Non-opioid Pain Patch Market to Reach US$2.4 Billion by 2032

The global market for Non-opioid Pain Patch estimated at US$1.8 Billion in the year 2025, is expected to reach US$2.4 Billion by 2032, growing at a CAGR of 4.3% over the analysis period 2025-2032. Lidocaine Patches Type, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$729.6 Million by the end of the analysis period. Growth in the Diclofenac Patches Type segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$487.9 Million While China is Forecast to Grow at 7.7% CAGR

The Non-opioid Pain Patch market in the U.S. is estimated at US$487.9 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$526.3 Million by the year 2032 trailing a CAGR of 7.7% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Non-Opioid Pain Patch Market - Key Trends & Drivers Summarized

What Is a Non-Opioid Pain Patch, and Why Is It So Crucial in Modern Pain Management?

A non-opioid pain patch is a transdermal delivery system designed to deliver medication through the skin to manage pain without the use of opioids. These patches provide a localized and sustained release of active ingredients, such as lidocaine, capsaicin, menthol, and diclofenac, which work to block pain signals or reduce inflammation in the affected area. By offering a non-systemic approach to pain relief, non-opioid pain patches reduce the risk of dependency, side effects, and other complications commonly associated with opioid painkillers.

The importance of non-opioid pain patches lies in their ability to provide effective, targeted pain relief while minimizing systemic side effects and addiction risks. As concerns about the opioid crisis continue to grow, the healthcare industry has increasingly focused on safer, alternative pain management solutions. Non-opioid pain patches are widely used for conditions like arthritis, neuralgia, muscle sprains, and post-surgical pain, offering patients a convenient and non-invasive treatment option. With a growing emphasis on non-addictive treatments and chronic pain management, non-opioid pain patches have become an essential tool in both clinical and home settings.

How Are Technological Advancements Shaping the Non-Opioid Pain Patch Market?

Technological advancements have significantly enhanced the design, effectiveness, and application of non-opioid pain patches, driving innovation across the pain management sector. One of the major developments is the improvement in transdermal delivery technology, which has led to more effective and sustained release of active ingredients. Modern pain patches incorporate advanced adhesive materials that ensure better skin adhesion and consistent drug delivery, even in challenging conditions like sweating or movement. This has made non-opioid pain patches more reliable for both short-term pain relief and long-term management of chronic pain conditions.

The integration of novel active ingredients and drug formulations has also improved the effectiveness of non-opioid pain patches. For example, advancements in lidocaine formulations have increased its penetration through the skin, enhancing its anesthetic effects for longer durations. Similarly, new formulations of capsaicin have been developed to reduce irritation while maintaining effective pain relief, making them more tolerable for patients with chronic neuropathic pain. Multi-layer patches that combine different active ingredients are being developed to target multiple pain pathways simultaneously, offering broader and more comprehensive pain relief.

Advancements in smart patch technology have introduced wearable, connected pain patches that allow patients and healthcare providers to monitor pain relief in real-time. These smart patches are equipped with sensors that track skin temperature, moisture levels, and drug release rates, providing data to optimize treatment and improve patient compliance. Additionally, micro-needling transdermal systems are being explored to enhance drug penetration for deeper and faster relief, particularly for conditions like osteoarthritis and severe neuralgia. These innovations not only improve the functionality of non-opioid pain patches but also align with broader trends toward personalized, patient-centric, and digital healthcare solutions.

What Are the Emerging Applications of Non-Opioid Pain Patches Across Different Medical Conditions?

Non-opioid pain patches are finding expanding applications across a range of medical conditions, driven by the need for safer and more effective pain management solutions. In musculoskeletal pain, such as arthritis, sprains, and strains, patches containing nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac provide targeted relief by reducing inflammation at the site of pain. These patches offer sustained relief for chronic conditions like osteoarthritis, helping patients manage daily pain while minimizing the systemic side effects associated with oral NSAIDs.

In neuropathic pain conditions, such as post-herpetic neuralgia, diabetic neuropathy, and nerve damage, non-opioid pain patches containing ingredients like lidocaine and capsaicin are commonly used. Lidocaine patches work by numbing the affected area, blocking pain signals, and providing localized relief without impacting the rest of the body. Capsaicin patches, derived from chili peppers, deplete substance P-a neurotransmitter involved in pain transmission-offering longer-lasting relief for chronic nerve pain conditions. These patches are often used as part of a multimodal pain management strategy to enhance patient outcomes in managing chronic neuropathic pain.

In postoperative pain management, non-opioid pain patches are used to provide localized relief after minor surgeries or invasive procedures. For example, lidocaine patches are applied to surgical incision sites to reduce pain and discomfort, allowing for faster recovery and greater patient mobility. In palliative care, non-opioid patches help manage cancer-related pain without adding to the risk of opioid dependency. The use of non-opioid patches in these settings highlights their role in improving patient comfort and reducing reliance on systemic pain medications.

In sports medicine and rehabilitation, non-opioid pain patches are used to manage acute injuries like muscle strains, tendonitis, and contusions. Menthol and methyl salicylate patches provide cooling and anti-inflammatory effects, making them suitable for athletes seeking quick pain relief without impacting performance. The expanding applications of non-opioid pain patches across these medical conditions underscore their critical role in delivering effective, localized, and safer pain relief across diverse patient populations.

What Drives Growth in the Non-Opioid Pain Patch Market?

The growth in the non-opioid pain patch market is driven by several factors, including increasing awareness of opioid addiction risks, rising prevalence of chronic pain conditions, and advancements in transdermal drug delivery technology. One of the primary growth drivers is the ongoing opioid crisis, which has led healthcare providers, patients, and regulatory agencies to seek safer, non-addictive alternatives for pain management. Non-opioid pain patches offer an effective solution that reduces the risk of dependency, aligns with public health goals, and supports better patient outcomes in managing both acute and chronic pain.

The rising prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain, has further fueled demand for non-opioid pain patches. As populations age and lifestyle-related conditions increase, the need for sustained, localized pain relief has become critical for maintaining quality of life. Non-opioid patches provide patients with a convenient and less invasive treatment option that can be used alone or as part of a multimodal pain management approach, supporting broader adoption in both clinical and home settings.

Advancements in transdermal drug delivery technologies have also contributed to market growth by making non-opioid pain patches more effective and user-friendly. Innovations in adhesive materials, drug formulations, and micro-encapsulation techniques have improved the performance, duration, and comfort of pain patches. The development of new active ingredients, combination patches, and smart monitoring features has increased the versatility of non-opioid patches, making them suitable for a wider range of pain conditions and patient needs.

Government regulations, public health initiatives, and increased healthcare funding for pain management have also played a significant role in driving the adoption of non-opioid pain patches. Regulatory agencies have encouraged the development of non-opioid alternatives as part of broader efforts to reduce opioid dependency and promote safer pain management options. Reimbursement policies and insurance coverage for non-opioid treatments have further supported market growth, making these patches more accessible to patients across various healthcare settings.

With ongoing innovations in drug delivery, personalized medicine, and wearable health technology, the non-opioid pain patch market is poised for continued growth. These trends, combined with increasing demand for safer, effective, and localized pain relief options, make non-opioid pain patches a vital component of modern pain management strategies across diverse patient populations and medical conditions.

SCOPE OF STUDY:

The report analyzes the Non-opioid Pain Patch market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type, Other Types); Technology (Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology, Microneedle-Enhanced Patches Technology); Indication (Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication, Other Indications); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Grunenthal Group
• GSK PLC
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Novartis AG
• Pfizer, Inc.
• Scilex Pharmaceuticals
• TEH SENG Pharmaceutical Mfg. Co., Ltd.
• Teikoku Seiyaku Co., Ltd.
• Teva Pharmaceutical Industries Ltd.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Non-opioid Pain Patch - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-addictive Pain Management Drives Non-opioid Patch Adoption
  • Growing Awareness of Opioid Alternatives Sets the Stage for Market Growth
  • Advancements in Transdermal Drug Delivery Propel Non-opioid Patch Market
  • Expanding Applications in Chronic Pain Management Strengthen Business Case
  • Increasing Demand for Pain Relief in Geriatric Population Enhances Market Scope
  • Use in Sports Injury Treatment Expands Addressable Market
  • Growing Use in Post-surgical Pain Management Drives Non-opioid Patch Demand
  • Increasing Use in Cancer-related Pain Propels Non-opioid Patch Market
  • Rising Preference for Home-based Pain Relief Solutions Sets the Stage for Growth
  • Use in Neuropathic Pain Drives Demand for Non-opioid Patches
  • Growing Applications in Rehabilitation Centers Enhance Market Potential
  • Increasing Demand for Non-invasive Treatments Drives Non-opioid Patch Market
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Non-opioid Pain Patch Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • TABLE 2: World Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 3: World Historic Review for Non-opioid Pain Patch by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 4: World 13-Year Perspective for Non-opioid Pain Patch by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 5: World Recent Past, Current & Future Analysis for Lidocaine Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 6: World Historic Review for Lidocaine Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 7: World 13-Year Perspective for Lidocaine Patches Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 8: World Recent Past, Current & Future Analysis for Diclofenac Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 9: World Historic Review for Diclofenac Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 10: World 13-Year Perspective for Diclofenac Patches Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 11: World Recent Past, Current & Future Analysis for Capsaicin Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 12: World Historic Review for Capsaicin Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 13: World 13-Year Perspective for Capsaicin Patches Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 14: World Recent Past, Current & Future Analysis for Ketoprofen Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 15: World Historic Review for Ketoprofen Patches Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 16: World 13-Year Perspective for Ketoprofen Patches Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 19: World 13-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 20: World Recent Past, Current & Future Analysis for Matrix Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 21: World Historic Review for Matrix Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 22: World 13-Year Perspective for Matrix Patches Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 23: World Recent Past, Current & Future Analysis for Reservoir Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 24: World Historic Review for Reservoir Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 25: World 13-Year Perspective for Reservoir Patches Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 26: World Recent Past, Current & Future Analysis for Drug-In-Adhesive Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 27: World Historic Review for Drug-In-Adhesive Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 28: World 13-Year Perspective for Drug-In-Adhesive Patches Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 29: World Recent Past, Current & Future Analysis for Microneedle-Enhanced Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 30: World Historic Review for Microneedle-Enhanced Patches Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 31: World 13-Year Perspective for Microneedle-Enhanced Patches Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 32: World Recent Past, Current & Future Analysis for Neuropathic Pain Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 33: World Historic Review for Neuropathic Pain Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 34: World 13-Year Perspective for Neuropathic Pain Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 35: World Recent Past, Current & Future Analysis for Musculoskeletal Pain Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 36: World Historic Review for Musculoskeletal Pain Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 37: World 13-Year Perspective for Musculoskeletal Pain Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 38: World Recent Past, Current & Future Analysis for Cancer-Associated Pain Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 39: World Historic Review for Cancer-Associated Pain Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 40: World 13-Year Perspective for Cancer-Associated Pain Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 42: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 43: World 13-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 44: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 45: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 46: World 13-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 47: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 48: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 49: World 13-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 50: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 51: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 52: World 13-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 53: USA Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 54: USA Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 55: USA 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 56: USA Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 57: USA Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 58: USA 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 59: USA Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 60: USA Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 61: USA 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 62: USA Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 63: USA Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 64: USA 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 66: Canada Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 67: Canada 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 69: Canada Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 70: Canada 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 72: Canada Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 73: Canada 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 75: Canada Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 76: Canada 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• JAPAN
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 78: Japan Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 79: Japan 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 81: Japan Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 82: Japan 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 84: Japan Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 85: Japan 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 87: Japan Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 88: Japan 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• CHINA
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 89: China Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 90: China Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 91: China 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 92: China Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 93: China Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 94: China 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 95: China Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 96: China Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 97: China 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 98: China Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 99: China Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 100: China 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• EUROPE
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 102: Europe Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 103: Europe 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 105: Europe Historic Review for Non-opioid Pain Patch by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 106: Europe 13-Year Perspective for Non-opioid Pain Patch by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 108: Europe Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 109: Europe 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 111: Europe Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 112: Europe 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 114: Europe Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 115: Europe 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• FRANCE
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 116: France Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 117: France Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 118: France 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 119: France Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 120: France Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 121: France 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 122: France Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 123: France Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 124: France 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 125: France Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 126: France Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 127: France 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• GERMANY
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 129: Germany Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 130: Germany 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 132: Germany Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 133: Germany 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 135: Germany Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 136: Germany 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 138: Germany Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 139: Germany 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 141: Italy Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 142: Italy 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 144: Italy Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 145: Italy 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 147: Italy Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 148: Italy 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 150: Italy Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 151: Italy 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 152: UK Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 153: UK Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 154: UK 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 155: UK Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 156: UK Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 157: UK 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 158: UK Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 159: UK Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 160: UK 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 161: UK Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 162: UK Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 163: UK 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 165: Spain Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 166: Spain 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 168: Spain Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 169: Spain 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 171: Spain Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 172: Spain 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 174: Spain Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 175: Spain 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 177: Russia Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 178: Russia 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 180: Russia Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 181: Russia 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 183: Russia Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 184: Russia 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 186: Russia Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 187: Russia 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 190: Rest of Europe 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 193: Rest of Europe 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 196: Rest of Europe 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 199: Rest of Europe 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• ASIA-PACIFIC
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Non-opioid Pain Patch by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 202: Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 205: Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 208: Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 211: Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 214: Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
• AUSTRALIA
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 216: Australia Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 217: Australia 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 219: Australia Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 220: Australia 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 222: Australia Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 223: Australia 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 225: Australia Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 226: Australia 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
• INDIA
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
  • TABLE 227: India Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 228: India Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 229: India 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 230: India Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 231: India Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 232: India 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 233: India Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 234: India Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 235: India 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
  • TABLE 236: India Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 237: India Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 238: India 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
• SOUTH KOREA
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 240: South Korea Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 241: South Korea 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 243: South Korea Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 244: South Korea 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 246: South Korea Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 247: South Korea 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 249: South Korea Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 250: South Korea 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
• REST OF ASIA-PACIFIC
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
• LATIN AMERICA
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 264: Latin America Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 265: Latin America 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 267: Latin America Historic Review for Non-opioid Pain Patch by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 268: Latin America 13-Year Perspective for Non-opioid Pain Patch by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 270: Latin America Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 271: Latin America 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 273: Latin America Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 274: Latin America 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 276: Latin America Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 277: Latin America 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 279: Argentina Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 280: Argentina 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 282: Argentina Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 283: Argentina 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 285: Argentina Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 286: Argentina 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 288: Argentina Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 289: Argentina 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 291: Brazil Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 292: Brazil 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 294: Brazil Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 295: Brazil 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 297: Brazil Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 298: Brazil 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 300: Brazil Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 301: Brazil 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 303: Mexico Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 304: Mexico 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 306: Mexico Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 307: Mexico 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 309: Mexico Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 310: Mexico 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 312: Mexico Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 313: Mexico 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 316: Rest of Latin America 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 319: Rest of Latin America 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 322: Rest of Latin America 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 325: Rest of Latin America 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 327: Middle East Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 328: Middle East 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 330: Middle East Historic Review for Non-opioid Pain Patch by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 331: Middle East 13-Year Perspective for Non-opioid Pain Patch by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 333: Middle East Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 334: Middle East 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 336: Middle East Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 337: Middle East 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 339: Middle East Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 340: Middle East 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 342: Iran Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 343: Iran 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 345: Iran Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 346: Iran 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 348: Iran Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 349: Iran 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 351: Iran Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 352: Iran 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 354: Israel Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 355: Israel 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 357: Israel Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 358: Israel 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 360: Israel Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 361: Israel 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 363: Israel Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 364: Israel 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 367: Saudi Arabia 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 370: Saudi Arabia 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 373: Saudi Arabia 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 376: Saudi Arabia 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 378: UAE Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 379: UAE 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 381: UAE Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 382: UAE 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 384: UAE Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 385: UAE 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 387: UAE Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 388: UAE 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 391: Rest of Middle East 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 394: Rest of Middle East 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 397: Rest of Middle East 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 400: Rest of Middle East 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032
• AFRICA
  • Non-opioid Pain Patch Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 402: Africa Historic Review for Non-opioid Pain Patch by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 403: Africa 13-Year Perspective for Non-opioid Pain Patch by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 405: Africa Historic Review for Non-opioid Pain Patch by Type - Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 406: Africa 13-Year Perspective for Non-opioid Pain Patch by Type - Percentage Breakdown of Value Sales for Lidocaine Patches Type, Diclofenac Patches Type, Capsaicin Patches Type, Ketoprofen Patches Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 408: Africa Historic Review for Non-opioid Pain Patch by Technology - Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 409: Africa 13-Year Perspective for Non-opioid Pain Patch by Technology - Percentage Breakdown of Value Sales for Matrix Patches Technology, Reservoir Patches Technology, Drug-In-Adhesive Patches Technology and Microneedle-Enhanced Patches Technology for the Years 2020, 2026 & 2032
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 411: Africa Historic Review for Non-opioid Pain Patch by Indication - Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 412: Africa 13-Year Perspective for Non-opioid Pain Patch by Indication - Percentage Breakdown of Value Sales for Neuropathic Pain Indication, Musculoskeletal Pain Indication, Cancer-Associated Pain Indication and Other Indications for the Years 2020, 2026 & 2032

IV. COMPETITION